Provides an overview of tumor microenvironment, the challenges and opportunities in developing stimuli-responsive and site-specific delivery nanoplatforms, and their related strategies for cancer treatment as well as toxicological and regulatory aspects. This illustrates their industrial applicability and commercialization prospects.